Cardihab is proud to support Medibank in a trial aiming to improve access to cardiac rehabilitation and prevent cardiac patients from experiencing a second serious event.
SmartCR, Cardihab’s digital cardiac rehabilitation app, will be provided to patients who participate in the Medibank Heart Health at Home trial. By providing phone-based counselling in combination with SmartCR, the Heart Health at Home trial will allow trial participants to access cardiac rehabilitation from the comfort and convenience of their home rather than a hospital setting.
CEO of Cardihab, Helen Souris, said involvement in the Medibank trial was an important milestone toward meeting the company’s vision of helping patients reach optimal health when at risk of, or living with, heart disease.
“Receiving timely access to cardiac rehabilitation services is a significant challenge for people who have experienced an acute cardiac event,” Helen said. “We are proud to be supporting Medibank in their endeavours to make a difference on such an important aspect of cardiac care.”
The Medibank Heart Health at Home trial for customers will include:
• Clinical care coordinators (such as a cardiac nurse or physiotherapist) to provide one to one support through weekly telephone consultations.
• Access to the Cardihab smart phone app to provide health and exercise monitoring, motivational and educational materials, and medication management tools.
• Exercise targets based on recommended activity post cardiac procedure.
Cardiovascular disease remains Australia’s largest killer, accounting for 44,000 deaths in 2017 and 1.1 million hospitalisations a year. It is expected to cost Australia $22 billion by 2032-33.[i]
People have already experienced a serious event, such as an acute heart attack, are at higher risk of suffering another serious event, with a Canadian study showing 61.7% were readmitted within a year.[ii]
Cardiac rehabilitation, a medically supervised exercise and information program for people who have had heart surgery or a serious heart event, has been shown to achieve a 26% reduction in mortality and an 18% reduction in readmissions, as well as quality of life benefits.[iii] Despite this, less than 30% of eligible patients participate.[iv]
In a clinical trial, Cardihab’s digital cardiac rehabilitation solution, which allows users to participate in a program in the comfort of their own home, demonstrated significantly higher rates vs traditional hospital-based cardiac rehab of:
- uptake (80% vs 62%),
- adherence (94% vs 68%) and
- completion (80% vs 47%)[v]
In addition, the home-based program was as effective in improving physiological and psychological health outcomes as traditional cardiac rehabilitation.
[i] Australian Bureau of Statistics 2018, Causes of Death 2017, ABS cat. no. 3303.0.
[ii] Southern DA, Ngo J, Martin BJ, Galbraith PD, Knudtson ML, Ghali WA, James MT and Wilton SB. Characterizing types of readmission after acute coronary syndrome hospitalization: implications for quality reporting. J Am Heart Assoc 2014;3:e001046
[iii] Anderson L, et al. Exercise – Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta – Analysis. J Am Coll Cardiol. 2016 Jan 5; 67(1):1 – 12. dol:10.1016/j.jacc.2015.10.044
[v] Varnﬁeld M, Karunanithi M, Lee C-K, et al. Heart 2014;100:1770–1779.
[iv] Clark RA, Conway A, Poulsen V, et al. Alternative models of cardiac rehabilitation: a systematic review. Eur J Prev Cardiol 2013; 0 (00), 1 – 40